BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salih S, Alkatheeri A, Alomaim W, Elliyanti A. Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges. Molecules 2022;27:5231. [DOI: 10.3390/molecules27165231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Destro G, Chen Z, Chan CY, Fraser C, Dias G, Mosley M, Guibbal F, Gouverneur V, Cornelissen B. A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy. Nucl Med Biol 2023;116-117:108312. [PMID: 36621256 DOI: 10.1016/j.nucmedbio.2022.108312] [Reference Citation Analysis]
2 Elliyanti A. Aspects Considered in Differentiated Thyroid Cancer for Radioiodine Therapy. Thyroid Cancer - The Road From Genes to Successful Treatment [Working Title] 2022. [DOI: 10.5772/intechopen.108481] [Reference Citation Analysis]
3 Rotariu T, Pulpea D, Toader G, Rusen E, Diacon A, Neculae V, Liggat J. Peelable Nanocomposite Coatings: “Eco-Friendly” Tools for the Safe Removal of Radiopharmaceutical Spills or Accidental Contamination of Surfaces in General-Purpose Radioisotope Laboratories. Pharmaceutics 2022;14:2360. [DOI: 10.3390/pharmaceutics14112360] [Reference Citation Analysis]